NOVOGENE CORPORATION INC - RNASEQ NEBNEXT ULTRA II (DIRECTIONAL) RNA WITH POLYA SELECTION NEXT GENERATION SEQUENCING ILLUMINA 2X150; 6GB ESTIMATED 40M PAIRED END READS (20M IN EACH DIRECTION) PER SAMPLE
Key Details
Description
RNASEQ NEBNEXT ULTRA II (DIRECTIONAL) RNA WITH POLYA SELECTION NEXT GENERATION SEQUENCING ILLUMINA 2X150; 6GB ESTIMATED 40M PAIRED END READS (20M IN EACH DIRECTION) PER SAMPLE
Context & Analysis
On Aug 9, 2021, Department of Health and Human Services obligated $13,386 to NOVOGENE CORPORATION INC for rnaseq nebnext ultra ii (directional) rna with polya selection next generation sequencing illumina 2x150; 6gb estimated 40m paired end reads (20m in each direction) per sample. The award is classified under NAICS 541380 — TESTING LABORATORIES AND SERVICES. Competition extent: competed under sap with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in SACRAMENTO, CA. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541380 — related awards are listed below.
Contractor Information
Related Federal Investment
Similar Awards
WASTEWATER SURVEILLANCE TESTING
VERILY HEALTH INC.
$42.3M
INNOVATION FUNNEL FOR COVID-19 - VALIDATION CENTER
EMORY UNIVERSITY
$41.2M
STUDY OF E-CIGARETTE AEROSOL TOXICITY IN IN VIVO NONCLINICAL MODELS.
LOVELACE BIOMEDICAL RESEARCH INSTITUTE
$38.8M
CENTRALIZED OMICS RESOURCE (CORE) YEAR 5
THE BROAD INSTITUTE, INC
$36.4M
NHLBI TRANS-OMICS FOR PRECISION MEDICINE (TOPMED) FOR THE CENTRALIZED OMICS RESOURCE (CORE) - TASK AREAS 2, 3, AND 4 - 2024 TASK ORDER
THE BROAD INSTITUTE, INC
$24.5M
Stay Updated
Get notified about new opportunities matching your interests.